Granahan Investment Management’s Core Laboratories CLB Stock Holding History

Granahan Investment Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,770	Closed	-$382K	–	224
2017 Q2	$382K	Sell	3,770 -8,506	-69%	-$917K	0.04%	185
2017 Q1	$1.42M	Sell	12,276 -117,924	-91%	-$13.7M	0.14%	148
2016 Q4	$15.6M	Buy	130,200 +8,100	+7%	+$897K	0.54%	75
2016 Q3	$13.7M	Buy	122,100 +6,800	+6%	+$783K	0.45%	95
2016 Q2	$14.3M	Buy	115,300 +30,250	+36%	+$3.65M	0.52%	77
2016 Q1	$9.56M	Buy	85,050 +17,250	+25%	+$1.79M	0.35%	99
2015 Q4	$7.37M	Sell	67,800 -6,900	-9%	-$790K	0.25%	124
2015 Q3	$7.46M	Buy	+74,700	New	+$8.12M	0.23%	141

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Granahan Investment Management's CLB Position: Q3 2017 in Review

Granahan Investment Management sold out of Core Laboratories (CLB) in Q3 2017, closing a stake of 3,770 shares — an estimated $382K sold.

Granahan Investment Management first reported a position in CLB in Q3 2015 and held it in 8 quarters. The position peaked at $15.6M in Q4 2016. 345 funds tracked by Wall St. Rank hold CLB as of Q3 2017.

Granahan Investment Management reported no remaining Core Laboratories position as of Q3 2017 after selling out during the quarter.
Granahan Investment Management sold 3,770 Core Laboratories shares in Q3 2017, an estimated $382K.
Granahan Investment Management first reported a position in Core Laboratories in Q3 2015 and held it in 8 quarters.
Granahan Investment Management's Core Laboratories position peaked at $15.6M in Q4 2016.
345 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2017.

Based on Granahan Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.